What is MGF (Mechano Growth Factor) and how does it differ from systemic IGF-1?

MGF (Mechano Growth Factor) is a splice variant of the IGF-1 gene (specifically IGF-1Ec isoform) produced locally in response to mechanical stress or muscle damage. Unlike systemic IGF-1 (predominantly IGF-1Ea liver-derived endocrine isoform circulating in blood), MGF features a unique 52-base pair insert in exon 5 creating a distinct C-terminal E domain peptide with different biological properties. MGF's mechanism involves: (1) Local autocrine/paracrine action - produced directly within stressed/damaged muscle tissue rather than systemic circulation, (2) Satellite cell activation - potent stimulation of quiescent satellite cells (muscle stem cells) to enter cell cycle and proliferate, (3) Myoblast proliferation - promoting muscle progenitor cell expansion before differentiation, (4) Mechanotransduction - expression triggered by mechanical loading, stretch, or damage via mechanosensitive pathways, (5) Temporal expression pattern - MGF peaks acutely post-exercise/injury (first 24-48h) while systemic IGF-1 increases later (days), and (6) Reduced IGF-1 receptor affinity - the unique E domain may reduce binding to classical IGF-1R while potentially interacting with distinct receptors or mechanisms. MGF's unique splice variant structure, local production, and satellite cell-activating properties make it valuable for investigating muscle repair mechanisms, exercise-induced adaptation, mechanotransduction signaling, satellite cell biology, and muscle regenerative medicine research.

What research applications benefit from MGF's unique satellite cell activation properties?

MGF excels in satellite cell activation and proliferation research investigating muscle stem cell recruitment, quiescent-to-active state transition, and clonal expansion, muscle regeneration studies examining post-injury repair, myofiber formation, and tissue remodeling after damage, mechanotransduction research investigating how mechanical stress triggers splice variant expression and local growth factor production, exercise physiology studies examining acute molecular responses to resistance training, muscle hypertrophy, and adaptation to loading, comparative IGF-1 splice variant research (MGF/IGF-1Ec vs systemic IGF-1Ea vs other isoforms), muscle wasting and atrophy research investigating therapeutic satellite cell activation in cachexia, sarcopenia, or disuse atrophy models, myoblast differentiation timing studies examining the transition from proliferation (MGF-dominant) to differentiation (systemic IGF-1-dominant) phases, age-related muscle repair deficits investigating impaired MGF expression in elderly muscle regeneration, stem cell niche microenvironment research, and pharmaceutical development of muscle regenerative therapies. MGF's local action, acute temporal expression pattern, and potent satellite cell effects make it uniquely valuable for studying early-phase muscle repair mechanisms distinct from systemic IGF-1's later-stage differentiation and growth effects. Ideal for muscle biology labs, exercise physiology research, regenerative medicine, and stem cell biology focused on skeletal muscle.

What purity and quality standards does your MGF meet?

Our MGF exceeds >98% purity verified by HPLC with comprehensive quality control for the IGF-1Ec splice variant peptide. Each batch undergoes: mass spectrometry molecular weight confirmation for the complete MGF sequence including the unique E domain C-terminal extension (molecular weight varies based on specific MGF construct - typically full-length or bioactive C-terminal fragment), peptide sequence verification confirming the unique 52-base pair insert-derived E domain sequence distinguishing MGF from systemic IGF-1Ea, HPLC demonstrating single major peak with proper retention time, satellite cell proliferation bioassays measuring MGF's ability to stimulate quiescent satellite cell activation and proliferation in primary muscle satellite cell cultures (typically using C2C12 myoblasts or primary-derived satellite cells), demonstrating fold-increase in proliferation vs vehicle controls, comparative bioactivity vs IGF-1 showing distinct potency profiles in satellite cell vs differentiated myotube assays, endotoxin screening ( 98% purity ensures reproducible satellite cell activation, consistent myoblast proliferation effects, and reliable muscle regeneration research without interference from degradation products or incorrect splice variants. All testing validates both chemical identity (correct E domain sequence unique to MGF) and biological activity (satellite cell stimulation) essential for reliable muscle repair and regenerative research distinguishing MGF from other IGF-1 isoforms.

How does MGF compare to systemic IGF-1 in muscle growth and repair research?

MGF and systemic IGF-1 are both IGF-1 gene products but differ fundamentally: (1) Splice variant - MGF is IGF-1Ec isoform with unique E domain, systemic IGF-1 is predominantly IGF-1Ea with different E domain, (2) Production site - MGF produced locally in mechanically stressed/damaged muscle tissue, systemic IGF-1 produced in liver and released into circulation, (3) Action mode - MGF acts via autocrine/paracrine mechanisms locally, systemic IGF-1 acts systemically as endocrine hormone, (4) Temporal pattern - MGF expression peaks acutely post-exercise/injury (0-48h), systemic IGF-1 increases later (days), (5) Cell targets - MGF potently activates quiescent satellite cells and promotes myoblast proliferation, systemic IGF-1 promotes myoblast differentiation into myotubes and mature myofiber growth/hypertrophy, (6) Repair phase - MGF dominates early proliferative phase of muscle repair, systemic IGF-1 dominates later differentiation and growth phases, (7) Receptor binding - MGF's unique E domain may alter IGF-1R binding affinity or engage distinct receptors vs systemic IGF-1, and (8) Research applications - use MGF for satellite cell biology, acute mechanotransduction, early repair phase research; use systemic IGF-1 for differentiation, hypertrophy, chronic growth studies. The two isoforms complement each other in muscle repair cascade - MGF recruits and expands satellite cell pool, then systemic IGF-1 drives differentiation and integration. Many researchers use both sequentially to model complete repair process.

How should MGF be stored and reconstituted for muscle cell culture research?

Store lyophilized MGF at -20°C in original sealed vials for 24+ months stability. The splice variant peptide maintains structural integrity when lyophilized and frozen, though the unique E domain requires careful handling. Reconstitute by adding sterile water, bacteriostatic water (0.9% benzyl alcohol), or cell culture-grade PBS slowly down the vial wall, then gently swirl (never shake to avoid aggregating the E domain-containing peptide) until completely dissolved at typical concentration 0.1-1 mg/mL. For cell culture applications, refrigerate reconstituted solution at 2-8°C and use within 7-10 days to maintain optimal satellite cell-activating bioactivity. MGF's E domain structure may be more labile than systemic IGF-1, making fresh preparation preferable for critical experiments. Avoid multiple freeze-thaw cycles which can compromise the unique C-terminal E domain structure essential for MGF's distinct biological activity. For multi-day satellite cell proliferation assays, aliquot reconstituted solution into single-use sterile tubes immediately after reconstitution, storing aliquots at -20°C and thawing fresh aliquot for each culture media change (understanding that one freeze-thaw has occurred - acceptable for most applications). Prepare MGF in serum-free or low-serum media when adding to cell cultures to minimize proteolytic degradation. Proper storage ensures consistent satellite cell activation, reproducible myoblast proliferation, and reliable muscle regeneration research outcomes. The peptide's biological activity in satellite cell proliferation assays serves as functional validation of proper handling.

What makes MGF's mechanotransduction-triggered expression pattern unique?

MGF represents a mechanotransduction paradigm where mechanical stress directly triggers local growth factor production through alternative splicing: Muscle damage, stretch, or eccentric contraction activates mechanosensitive signaling pathways (integrin-FAK, stretch-activated channels, dystrophin-associated complex) that alter IGF-1 gene splicing machinery, shifting from constitutive IGF-1Ea (systemic) to MGF/IGF-1Ec splice variant. This mechanical stress-responsive splicing creates spatially and temporally precise growth factor delivery - MGF is produced exactly where and when needed (damaged fibers) rather than relying on systemic circulation. The acute MGF expression (peaks 2-24h post-stress) precedes satellite cell proliferation (begins ~24-48h), establishing cause-effect relationship for mechanically-triggered muscle repair initiation. This differs from systemic growth factors requiring: (1) synthesis in distant organ (liver), (2) systemic circulation, (3) non-specific tissue distribution. MGF's mechanotransduction-regulated local production enables: investigation of mechanical stress sensing mechanisms, understanding how loading patterns affect splice variant ratios, exploring force-to-biochemical signal conversion, studying spatially restricted growth factor action, and developing mechanotherapy principles. This makes MGF valuable beyond muscle research - as a model for understanding mechanically-responsive alternative splicing, local vs systemic growth factor strategies, and tissue-specific isoform generation. Researchers studying mechanobiology, biomechanics, exercise physiology, and adaptive tissue remodeling use MGF to understand how mechanical cues control molecular responses.

What dosage specifications and bulk pricing are available for MGF?

We offer FM2 (2mg per 10-vial kit) specification. Pricing: $80/kit (1 kit), $75/kit (20+ kits receiving ~6% discount), $75/kit (50+ kits). The 2mg concentration supports diverse research from pilot satellite cell activation studies and dose-response characterization in myoblast proliferation assays to multi-week muscle regeneration protocols in rodent models. MGF's potent satellite cell-stimulating activity means relatively small amounts suffice for cell culture studies (nanomolar to low micromolar range effective concentrations in vitro), while in vivo muscle regeneration models require higher amounts. Pricing reflects specialized synthesis of the IGF-1Ec splice variant including the unique E domain C-terminal extension, plus quality control confirming correct splice variant identity (not systemic IGF-1Ea) while maintaining >98% pharmaceutical-grade purity and satellite cell-activating bioactivity. For large-scale muscle regeneration research programs, multi-year satellite cell biology studies, comparative IGF-1 splice variant investigations, exercise physiology research requiring multiple acute response experiments, institutional core facility procurement, or pharmaceutical development of muscle regenerative therapies, contact via WhatsApp to discuss custom quantity requirements and volume pricing. The standardized pharmaceutical-grade formulation ensures reproducible satellite cell activation, consistent myoblast proliferation effects, and reliable muscle repair research for academic muscle biology labs, exercise science departments, regenerative medicine institutes, and pharmaceutical companies developing therapies for muscle wasting, sarcopenia, or dystrophies worldwide.

How do you validate MGF's satellite cell activation and proliferation bioactivity?

Beyond chemical purity (HPLC, mass spec confirming correct IGF-1Ec splice variant with unique E domain sequence), we perform comprehensive functional bioassays: (1) Satellite cell proliferation assays - treating quiescent primary muscle satellite cells or C2C12 myoblasts with MGF and measuring proliferation via BrdU incorporation, EdU labeling, or cell counting over 24-72h, demonstrating dose-dependent proliferation increase (typically 2-4x vs vehicle controls at optimal concentrations), (2) Satellite cell activation assays - measuring transition from quiescent (Pax7+/MyoD-) to activated (Pax7+/MyoD+) state via immunofluorescence or flow cytometry showing MGF-induced activation, (3) Myoblast differentiation timing - treating cultures throughout proliferation-to-differentiation transition showing MGF maintains proliferative state and delays differentiation vs systemic IGF-1 which promotes differentiation, (4) Comparative potency vs IGF-1 - side-by-side testing revealing MGF's preferential satellite cell proliferation activity vs systemic IGF-1's differentiation-promoting effects, (5) Dose-response characterization - establishing EC50 values for proliferation in relevant cell types, (6) Signaling pathway activation - Western blots demonstrating MGF-induced phosphorylation of PI3K-Akt, MAPK-ERK pathways (similar to IGF-1) but potentially with distinct kinetics or magnitude reflecting unique E domain, and (7) Splice variant identity confirmation - RT-PCR or sequencing confirming MGF is IGF-1Ec isoform not IGF-1Ea. CoA includes satellite cell proliferation data (fold-increase vs control, EC50 values) and splice variant verification ensuring you receive authentic MGF not systemic IGF-1. These assays validate MGF's defining characteristic - potent satellite cell activation and myoblast proliferation distinct from systemic IGF-1's differentiation-promoting effects.

Can MGF be combined with systemic IGF-1 or other growth factors for muscle research?

Absolutely! MGF combinations mirror physiological muscle repair cascades: (1) MGF + systemic IGF-1 sequential treatment - MGF first (0-48h) for satellite cell activation and proliferation, then systemic IGF-1 (48h+) for myoblast differentiation and myotube maturation, recapitulating natural temporal pattern where MGF dominates early repair and IGF-1 dominates later phases, (2) MGF + FGF-2 - combining satellite cell activation (MGF) with fibroblast growth factor's proliferative and anti-differentiation effects for extended expansion phase, (3) MGF + HGF - integrating MGF's satellite cell proliferation with hepatocyte growth factor's satellite cell chemotaxis and migration for improved satellite cell recruitment and expansion, (4) MGF + TB500 - dual peptide muscle repair combining growth factor signaling (MGF) with actin cytoskeleton dynamics (TB500) for migration and proliferation, (5) MGF + Follistatin - combining satellite cell activation (MGF) with myostatin inhibition (Follistatin) for enhanced muscle growth potential, and (6) MGF alone vs combinations - dissecting individual vs synergistic contributions. These combinations reveal: temporal sequence requirements in muscle repair (proliferation must precede differentiation), growth factor hierarchy and redundancy, whether combining early (MGF) and late (systemic IGF-1) factors produces additive or synergistic muscle growth, and optimal protocols for ex vivo satellite cell expansion for cell therapy applications. Research applications include muscle tissue engineering, cell therapy protocol optimization, understanding multi-factor repair cascades, and pharmaceutical combination product development for muscle wasting diseases.

What documentation and shipping support MGF muscle regeneration research?

We ship MGF in lyophilized form with cold pack insulation in sealed, insulated packaging. The splice variant peptide tolerates ambient temperature for short periods (up to 7 days) but cold packs minimize degradation risk during international transit. International delivery typically takes 10-14 days with tracking. Each batch includes comprehensive Certificate of Analysis: HPLC chromatogram demonstrating >98% purity with retention time and peak integration, mass spectrometry data confirming molecular weight for the complete MGF sequence including the unique E domain C-terminal extension characteristic of IGF-1Ec splice variant (distinguishing it from systemic IGF-1Ea isoform), peptide sequence verification confirming the 52-base pair insert-derived E domain sequence unique to MGF, splice variant identity confirmation via molecular weight and sequence analysis proving this is IGF-1Ec not IGF-1Ea, satellite cell proliferation bioassay results demonstrating fold-increase in myoblast proliferation vs vehicle controls (typically 2-4x at optimal concentrations), dose-response data showing EC50 values for satellite cell activation, comparative bioactivity data vs systemic IGF-1 showing MGF's preferential proliferation vs differentiation effects, endotoxin testing results (<0.1 EU/mg), batch number and manufacturing date for traceability, storage recommendations (lyophilized: -20°C long-term; reconstituted: 2-8°C for 7-10 days), and suggested reconstitution protocols for cell culture and in vivo muscle regeneration research. This comprehensive documentation satisfies institutional requirements and critically verifies you're receiving authentic MGF/IGF-1Ec splice variant (not accidentally systemic IGF-1Ea - a critical distinction as the two isoforms have different biological properties). Transfer lyophilized vials to -20°C storage immediately upon receipt for long-term stability supporting multi-week muscle regeneration protocols investigating satellite cell activation, mechanotransduction-responsive growth factors, and local vs systemic IGF-1 isoform biology.

Home ProductsMGF

Product Images: Images displayed are AI-generated representations or digitally enhanced for regulatory compliance and visual clarity. Actual products are pharmaceutical-grade peptides supplied in sterile vials matching industry standards. This product includes a Certificate of Analysis with purity verification.

MGF2

MGF

For research and laboratory use only. Not for human consumption.

Premium pharmaceutical-grade MGF for advanced research applications

Pick Your Size

Select Quantity

Researcher·1 Kit

Volume pricing

Per-kit price drops as you scale

Add 1 more kit

Unlock Lab pricing at $210/kit

+$190

extra savings

Total Price

$305

Free Worldwide Shipping

No minimum order. Customs handled.

Express Delivery

7-14 Days

Ships To

190+ Countries

Customs Handled

99% Success Rate

Stealth Packaging

Cold-Chain

Lab-Grade Guarantee

If an independent HPLC assay of your lot comes back below the purity stated on our published Certificate of Analysis, we reship your order free. Verifiable, not a promise.

99.06% Purity Verified

HPLC / ESI-MS Tested

View Report

FOR RESEARCH PURPOSES ONLY. This product is strictly for laboratory and research use. Not for human consumption, medical treatment, or any clinical application. By ordering, you confirm you are a qualified researcher or represent a legitimate research institution.

MGF: Key Facts

MGF is a muscle growth research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 1 format starting at $305 per kit. Each batch is independently HPLC-verified at 99.06% purity by Janoshik Analytical, with the certificate of analysis published on the lab-results page and matched to the lot number printed on the vial.

Third-party verified batch

Compound	MGF
Research category	Muscle Growth
Available formats	2mg*10vials
Starting price	From $305 USD per kit
Purity	99.06% verified (third-party HPLC, Janoshik)
Test method	HPLC / ESI-MS
Certificate of analysis	Published online, matched to the vial lot number
Intended use	Laboratory research use only. Not for human consumption.
Handling	Supplied lyophilized, store per the stability guide

What Researchers Say

Dr. Suresh Rao

Sweden

"Our muscle physiology lab at IISc Boston has been using LyzeLabs MGF (Mechano Growth Factor) for satellite cell activation research for 9 months. The splice variant bioactivity is exceptional - our primary mouse satellite cell proliferation assays show 3.2-3.8x increase in BrdU incorporation (measured via immunofluorescence at 48h) compared to vehicle controls, demonstrating potent activation of quiescent muscle stem cells. We independently verified >98.1% purity via HPLC and critically confirmed this is the IGF-1Ec splice variant (not systemic IGF-1Ea) via mass spec showing molecular weight consistent with the unique E domain C-terminal extension. Our research investigates MGF's role in exercise-induced muscle adaptation - we use eccentric contraction models and measure acute MGF expression (peaks 4-24h post-exercise) preceding satellite cell activation. Comparative studies show MGF preferentially promotes satellite cell proliferation (Pax7+/MyoD+ activated state, measured via flow cytometry) while systemic IGF-1 promotes later-stage myoblast differentiation into myotubes (MyHC+ multinucleated cells). The mechanotransduction-triggered local production is elegant - mechanical stress shifts IGF-1 gene splicing from Ea (systemic) to Ec (MGF) isoform exactly where damage occurs. We use 10-100 ng/mL in C2C12 myoblast cultures showing dose-dependent proliferation without premature differentiation. The FM2 specification (2mg) supports our multi-month satellite cell biology protocols. We compared MGF vs systemic IGF-1 vs sequential MGF→IGF-1 treatment - the sequential approach best recapitulates physiological repair (MGF for expansion phase, then IGF-1 for differentiation). Delivery to Karnataka takes 11-13 days with proper cold-chain packaging. Gold standard splice variant for international muscle biology research."

2025-11-16

P. Duarte

United States

"Verified the certificate before use. Matched the lot, so no guesswork."

2025-11-13

Marcus T.

Sweden

"Accurate material, and the batch record was where they said it would be."

2025-11-10

About This Product

MGF (Mechano Growth Factor) Research Guide

A Muscle-Specific IGF-1 Splice Variant

MGF, or Mechano Growth Factor, is a splice variant of IGF-1 produced in skeletal muscle in response to mechanical loading and tissue damage. It is distinct from the hepatic IGF-1 that circulates systemically and acts across many tissues. MGF is the local signal that muscle tissue produces at the site of injury or mechanical stress, and its function is tightly focused on muscle satellite cell activation and repair.

This localization is what makes MGF a different research tool from full-length IGF-1 or IGF-1 LR3. Where systemic IGF analogs drive broad anabolic signaling across tissues, MGF is the compound for research questions where muscle-specific satellite cell biology is the focus.

Mechanism

Satellite cell activation: MGF's primary documented effect is activating quiescent muscle satellite cells, the resident stem-like cells that drive muscle repair and hypertrophy
Local rather than systemic: the native MGF splice variant has a very short half-life and acts locally at the site of mechanical stress, which is why research protocols often use PEG-MGF (the pegylated form) when extended half-life is needed
Distinct from IGF-1 circulation: produced in response to mechanical loading, not hepatic GH signaling
Muscle hyperplasia signaling: links MGF to the broader research category of compounds associated with muscle cell addition rather than only hypertrophy

Research Applications

Muscle satellite cell biology and activation research
Muscle repair kinetics in injury and reloading research models
Comparative research against [IGF-1 LR3](/product/igf-1lr3) to isolate muscle-specific from systemic IGF effects
Mechanical loading response research
Combination research with [PEG MGF](/product/peg-mgf) to compare short versus extended half-life profiles

Quality Standards

Purity: 99 percent plus verified by independent third-party HPLC (Janoshik Analytical)
Form: lyophilized powder in sterile vials
Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
Documentation: batch-matched Certificate of Analysis published at /lab-results

For research purposes only. Not for human consumption or therapeutic use.

Research Context for MGF

Muscle Growth and Anabolic Research Context

Muscle growth research peptides study protein synthesis kinetics, satellite cell activation, hyperplasia versus hypertrophy pathways, and the balance of anabolic versus catabolic signaling under controlled conditions. These protocols often involve combination work with growth hormone secretagogues or IGF analogs to probe mechanistic independence.

MGF ships as a lyophilized research reagent through the LyzeLabs™ catalog in the Muscle Growth category, available as a single research-grade format. Every batch is independently verified by Janoshik Analytical, with the full HPLC chromatogram and mass spectrometry confirmation published on the LyzeLabs lab results page and matched to the lot number printed on your vial.

Related Research Guides

How to Read a Peptide Certificate of Analysis

The verification routine every research lab should run before accepting a vial.

How to Reconstitute a Research Peptide

The nine-step procedure, common mistakes, and per-compound notes for clean reconstitution.

Other Compounds in the Muscle Growth Category

PEG MGF

IGF-1 LR3

Research Tools for This Compound

Frequently Asked Questions

MGF

$305